David Sidransky - 12 Oct 2022 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role
Director
Signature
/s/ David Sidransky
Issuer symbol
CSBR
Transactions as of
12 Oct 2022
Net transactions value
-$1.69
Form type
4
Filing time
14 Oct 2022, 14:27:02 UTC
Previous filing
15 Jun 2022
Next filing
17 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSBR Common Stock Options Exercise $26,749 +8,333 +1.1% $3.21 770,605 12 Oct 2022 Direct
transaction CSBR Common Stock Tax liability $26,751 -3,562 -0.46% $7.51 767,043 12 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSBR Option to purchase Common Stock Options Exercise $0 -8,333 -100% $0.000000* 0 12 Oct 2022 Common Stock 8,333 $3.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
F2 The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018